SitesBLAST
Comparing WP_013842638.1 NCBI__GCF_000215085.1:WP_013842638.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
7mfjBBB Beta-cyanoalanine synthase (see paper)
49% identity, 96% coverage: 8:311/318 of query aligns to 16:319/319 of 7mfjBBB
6xo2A Structural characterization of beta cyanoalanine synthase from tetranychus urticae (two-spotted spider mite) (see paper)
46% identity, 96% coverage: 8:311/318 of query aligns to 17:293/294 of 6xo2A
- binding pyridoxal-5'-phosphate: L53 (≠ M45), K54 (= K46), N84 (= N76), C195 (≠ V188), G196 (= G189), T197 (= T190), G198 (≠ S191), C200 (≠ T193), I226 (≠ L221), T259 (= T279), C287 (= C305), D288 (= D306)
5xoqA Crystal structure of o-acetylserine sulfhydrylase with bound transcription factor peptide inhibitor from planctomyces limnophilus
46% identity, 97% coverage: 11:318/318 of query aligns to 10:307/310 of 5xoqA
- binding : T72 (= T73), S73 (= S74), G74 (= G75), T76 (= T77), M123 (≠ G124), Q144 (= Q155), R218 (≠ K230), H219 (= H231), Q222 (= Q234), G223 (= G235), A226 (≠ Y238)
P9WP55 O-acetylserine sulfhydrylase; OAS sulfhydrylase; OASS; Cysteine synthase A; CSase A; O-acetylserine (thiol)-lyase A; OAS-TL A; O-acetylserine-specific cysteine synthase; Sulfide-dependent cysteine synthase; EC 2.5.1.47 from Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) (see paper)
43% identity, 98% coverage: 6:317/318 of query aligns to 4:305/310 of P9WP55
- K44 (= K46) modified: N6-(pyridoxal phosphate)lysine
- N74 (= N76) binding pyridoxal 5'-phosphate
- GTGGT 178:182 (≠ GTSGT 189:193) binding pyridoxal 5'-phosphate
- S266 (≠ T279) binding pyridoxal 5'-phosphate
2q3dA 2.2 a resolution crystal structure of o-acetylserine sulfhydrylase (oass) from mycobacterium tuberculosis in complex with the reaction intermediate alpha-aminoacrylate (see paper)
43% identity, 98% coverage: 6:317/318 of query aligns to 4:305/306 of 2q3dA
- active site: K44 (= K46), S266 (≠ T279), P293 (≠ C305)
- binding 2-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-amino]-propionic acid: K44 (= K46), T71 (= T73), S72 (= S74), N74 (= N76), T75 (= T77), Q144 (= Q155), V177 (= V188), G178 (= G189), T179 (= T190), G180 (≠ S191), T182 (= T193), G222 (= G235), I223 (≠ S236), S266 (≠ T279), P293 (≠ C305), D294 (= D306)
2efyA Crystal structure of t.Th. Hb8 o-acetylserine sulfhydrylase complexed with 4-acetylbutyric acid
44% identity, 96% coverage: 12:317/318 of query aligns to 6:301/302 of 2efyA
- active site: K40 (= K46), S70 (= S74), E200 (= E214), S204 (≠ A218), S263 (≠ T279)
- binding 5-oxohexanoic acid: T69 (= T73), G71 (= G75), T73 (= T77), Q141 (= Q155), G175 (= G189), G219 (= G235), M220 (≠ S236), P222 (≠ Y238)
- binding pyridoxal-5'-phosphate: K40 (= K46), N72 (= N76), Y172 (≠ D186), G175 (= G189), T176 (= T190), G177 (≠ S191), T179 (= T193), G219 (= G235), S263 (≠ T279), P289 (≠ C305), D290 (= D306)
2ecqA Crystal structure of t.Th. Hb8 o-acetylserine sulfhydrylase complexed with 3-hydroxylactate
44% identity, 96% coverage: 12:317/318 of query aligns to 6:301/302 of 2ecqA
- active site: K40 (= K46), S70 (= S74), E200 (= E214), S204 (≠ A218), S263 (≠ T279)
- binding (3s)-3-hydroxybutanoic acid: K40 (= K46), G71 (= G75), T73 (= T77), Q141 (= Q155), G219 (= G235)
- binding pyridoxal-5'-phosphate: K40 (= K46), N72 (= N76), Y172 (≠ D186), G173 (≠ V187), G175 (= G189), T176 (= T190), T179 (= T193), G219 (= G235), S263 (≠ T279), P289 (≠ C305)
2ecoA Crystal structure of t.Th. Hb8 o-acetylserine sulfhydrylase complexed with 4-methylvalerate
44% identity, 96% coverage: 12:317/318 of query aligns to 6:301/302 of 2ecoA
- active site: K40 (= K46), S70 (= S74), E200 (= E214), S204 (≠ A218), S263 (≠ T279)
- binding 4-methyl valeric acid: K40 (= K46), T69 (= T73), G71 (= G75), T73 (= T77), Q141 (= Q155), G175 (= G189), T176 (= T190), G219 (= G235)
- binding pyridoxal-5'-phosphate: K40 (= K46), N72 (= N76), Y172 (≠ D186), G175 (= G189), T176 (= T190), T179 (= T193), G219 (= G235), S263 (≠ T279), P289 (≠ C305), D290 (= D306)
2bhtA Crystal structure of o-acetylserine sulfhydrylase b (see paper)
39% identity, 98% coverage: 7:317/318 of query aligns to 2:292/294 of 2bhtA
- active site: K41 (= K46), S69 (= S74), Q199 (≠ E214), G203 (≠ A218), S255 (≠ T279), C280 (= C305)
- binding pyridoxal-5'-phosphate: K41 (= K46), N71 (= N76), M173 (≠ V188), G174 (= G189), T175 (= T190), T176 (≠ S191), T178 (= T193), G208 (= G223), S255 (≠ T279), C280 (= C305)
4lmbA Crystal structure analysis of o-acetylserine sulfhydrylase cysk2 complexed with cystine from microcystis aeruginosa 7806 (see paper)
43% identity, 98% coverage: 6:318/318 of query aligns to 4:309/310 of 4lmbA
- active site: K46 (= K46), S269 (≠ T279)
- binding cysteine: K46 (= K46), T74 (= T73), S75 (= S74), N77 (= N76), T78 (= T77), M101 (≠ N100), M125 (≠ G124), M125 (≠ G124), Q147 (= Q155), F148 (= F156), Q224 (= Q234), G225 (= G235), G225 (= G235), I226 (≠ S236), A228 (≠ Y238)
- binding pyridoxal-5'-phosphate: K46 (= K46), N77 (= N76), V180 (= V188), G181 (= G189), T182 (= T190), G183 (≠ S191), T185 (= T193), G225 (= G235), S269 (≠ T279), P296 (≠ D306)
P16703 Cysteine synthase B; CSase B; O-acetylserine (thiol)-lyase B; OAS-TL B; O-acetylserine sulfhydrylase B; EC 2.5.1.47 from Escherichia coli (strain K12) (see paper)
39% identity, 98% coverage: 7:317/318 of query aligns to 2:292/303 of P16703
- N71 (= N76) binding pyridoxal 5'-phosphate
- S255 (≠ T279) binding pyridoxal 5'-phosphate
4lmaA Crystal structure analysis of o-acetylserine sulfhydrylase cysk1 from microcystis aeruginosa 7806 (see paper)
44% identity, 97% coverage: 9:318/318 of query aligns to 7:309/318 of 4lmaA
3zeiA Structure of the mycobacterium tuberculosis o-acetylserine sulfhydrylase (oass) cysk1 in complex with a small molecule inhibitor (see paper)
43% identity, 97% coverage: 6:312/318 of query aligns to 4:300/300 of 3zeiA
- active site: K44 (= K46), S266 (≠ T279), P293 (≠ C305)
- binding 3-[(Z)-[(5Z)-5-[[2-(2-hydroxy-2-oxoethyloxy)phenyl]methylidene]-3-methyl-4-oxidanylidene-1,3-thiazolidin-2-ylidene]amino]benzoic acid: T71 (= T73), S72 (= S74), I126 (≠ Q128), Q144 (= Q155), F145 (= F156), K215 (≠ N228), G222 (= G235), A225 (≠ Y238), F227 (≠ K240)
- binding pyridoxal-5'-phosphate: K44 (= K46), N74 (= N76), V177 (= V188), G178 (= G189), T179 (= T190), G180 (≠ S191), T182 (= T193), G222 (= G235), S266 (≠ T279), P293 (≠ C305), D294 (= D306)
2q3cA 2.1 a resolution crystal structure of o-acetylserine sulfhydrylase (oass) holoenzyme from mycobacterium tuberculosis in complex with the inhibitory peptide dfsi (see paper)
43% identity, 97% coverage: 6:312/318 of query aligns to 4:300/300 of 2q3cA
- active site: K44 (= K46), S266 (≠ T279), P293 (≠ C305)
- binding : T71 (= T73), S72 (= S74), G73 (= G75), T75 (= T77), M122 (≠ G124), Q144 (= Q155), K215 (≠ N228), G222 (= G235), A225 (≠ Y238)
4pcuA Crystal structure of delta516-525 e201s human cystathionine beta- synthase with adomet (see paper)
40% identity, 99% coverage: 2:316/318 of query aligns to 31:342/486 of 4pcuA
- active site: K77 (= K46), S105 (= S74), D237 (≠ E214), S305 (≠ T279)
- binding protoporphyrin ix containing fe: A182 (≠ P159), P185 (≠ C162), L186 (≠ A163), Y189 (= Y166), R222 (≠ T199), T269 (≠ A243)
- binding pyridoxal-5'-phosphate: K77 (= K46), N107 (= N76), G212 (= G189), T213 (= T190), G214 (≠ S191), T216 (= T193), G261 (= G235), S305 (≠ T279), P331 (≠ C305), D332 (= D306)
Sites not aligning to the query:
- binding protoporphyrin ix containing fe: 8, 9, 10, 11, 12, 20, 21, 22, 23
- binding s-adenosylmethionine: 376, 396, 397, 398, 399, 476, 478, 479
8s5hA Full-length human cystathionine beta-synthase with c-terminal 6xhis- tag, basal state, helical reconstruction (see paper)
40% identity, 99% coverage: 2:316/318 of query aligns to 32:345/507 of 8s5hA
Sites not aligning to the query:
7qgtB Crystal structure of human cystathionine beta-synthase (delta516-525) in complex with aoaa. (see paper)
40% identity, 99% coverage: 2:316/318 of query aligns to 33:346/500 of 7qgtB
- binding protoporphyrin ix containing fe: A186 (≠ P159), P189 (≠ C162), L190 (≠ A163), Y193 (= Y166), R226 (≠ T199)
- binding 4'-deoxy-4'-acetylyamino-pyridoxal-5'-phosphate: K79 (= K46), T106 (= T73), S107 (= S74), N109 (= N76), T110 (= T77), Q182 (= Q155), G216 (= G189), T217 (= T190), G218 (≠ S191), T220 (= T193), G265 (= G235), S309 (≠ T279), P335 (≠ C305), D336 (= D306)
Sites not aligning to the query:
P35520 Cystathionine beta-synthase; Beta-thionase; Serine sulfhydrase; EC 4.2.1.22 from Homo sapiens (Human) (see 40 papers)
40% identity, 99% coverage: 2:316/318 of query aligns to 73:386/551 of P35520
- P78 (≠ S7) to R: in CBSD; severe form; associated in cis with N-102; decreased cystathionine beta-synthase activity; decreased homotetramer formation; dbSNP:rs786204608
- G85 (= G14) to R: in CBSD; loss of cystathionine beta-synthase activity; dbSNP:rs863223435
- T87 (= T16) to N: in CBSD; decreased cystathionine beta-synthase activity; increased aggregation
- L101 (= L28) to P: in CBSD; common mutation in Irish population; loss of activity; dbSNP:rs786204757
- K102 (≠ P29) to N: in CBSD; associated in cis with R-78; decreased cystathionine beta-synthase activity; decreased homotetramer formation; dbSNP:rs786204609; to Q: in dbSNP:rs34040148
- C109 (≠ A36) to R: in CBSD; loss of activity; dbSNP:rs778220779
- A114 (≠ P41) to V: in CBSD; mild form; when linked with W-58 severe form; decreased cystathionine beta-synthase activity; decreases homotetramer formation by promoting formation of larger aggregates; dbSNP:rs121964964
- K119 (= K46) modified: N6-(pyridoxal phosphate)lysine
- R125 (≠ K52) to Q: in CBSD; severe form; when linked with D-131 moderate form; loss of cystathionine beta-synthase activity; decreased homotetramer formation; dbSNP:rs781444670; to W: in CBSD; exhibits an activity lower than 4% of the wild-type enzyme; absent capacity to form multimeric quaternary structure; dbSNP:rs886057100
- M126 (= M53) to V: in CBSD; loss of activity
- E131 (= E58) to D: in CBSD; linked with Q-125; loss of activity; dbSNP:rs1555875351
- G139 (= G66) to R: in CBSD; mild form; dbSNP:rs121964965
- I143 (≠ L70) to M: in CBSD; 4% of activity; stable; dbSNP:rs370167302
- E144 (= E71) to K: in CBSD; loss of cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; decreased homotetramer formation; dbSNP:rs121964966
- G148 (= G75) to R: in CBSD; loss of cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; loss of homotetramer formation; dbSNP:rs755952006
- N149 (= N76) binding pyridoxal 5'-phosphate
- L154 (= L81) to Q: in CBSD; protein expression is comparable to wild-type; significant decrease of enzyme activity
- A155 (= A82) to T: in CBSD; complete loss of activity; severely affects homotetramer formation by promoting formation of larger aggregates; dbSNP:rs1429138569; to V: in CBSD; protein expression is comparable to wild-type; significant decrease of enzyme activity
- C165 (≠ F92) to Y: in CBSD; severe form; protein expression is comparable to wild-type; loss of cystathionine beta-synthase activity; no effect on homotetramer formation; dbSNP:rs1347651454
- M173 (≠ N100) to V: in CBSD; presents 40% of the wild-type activity; highly reduced capacity to form multimeric quaternary structure; natural variant: Missing (in CBSD; loss of activity)
- E176 (= E103) to K: in CBSD; severe form; loss of cystathionine beta-synthase activity; inhibited by AdoMet; severely decreases homotetramer formation by promoting formation of larger aggregates; dbSNP:rs762065361
- V180 (≠ I107) to A: in CBSD; decreased cystathionine beta-synthase activity; decreases homotetramer formation; dbSNP:rs1555875010
- T191 (≠ V118) to M: in CBSD; moderate and severe forms; loss of cystathionine beta-synthase activity; absent capacity to form multimeric quaternary structure; dbSNP:rs121964973
- K211 (≠ Q145) modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
- A226 (≠ P159) to T: in CBSD; presents 20% of the wild-type activity; dramatically reduced capacity to form multimeric quaternary structure; dbSNP:rs763835246
- N228 (= N161) to K: in CBSD; loss of cystathionine beta-synthase activity; decreased homotetramer formation; dbSNP:rs1464223176; to S: in CBSD; has significantly decreased levels of enzyme activity; dbSNP:rs1555874803
- A231 (≠ G164) to P: in CBSD; has significantly decreased levels of enzyme activity
- D234 (≠ E167) to N: in CBSD; decreased cystathionine beta-synthase activity; changed localization; decreased interaction with pyridoxal 5'-phosphate; no effect on homotetramer formation; dbSNP:rs773734233; natural variant: Missing (in CBSD; protein expression is comparable to wild-type; significant decrease of enzyme activity)
- GTGGT 256:260 (≠ GTSGT 189:193) binding pyridoxal 5'-phosphate
- T257 (= T190) to M: in CBSD; moderate to severe form; protein expression is comparable to wild-type; significant decrease of enzyme activity; dbSNP:rs758236584
- T262 (= T195) to M: in CBSD; moderate form; dbSNP:rs149119723; to R: in CBSD; severe form; loss of cystathionine beta-synthase activity; loss of homotetramer formation
- R266 (≠ T199) to K: in CBSD; mild form; decreased cystathionine beta-synthase activity; decreased homotetramer formation; no effect on heme-binding; decreased stability; dbSNP:rs121964969
- K269 (= K202) natural variant: Missing (in CBSD; loss of expression)
- C272 (≠ D205) mutation to A: Reduced heme content and cystathionine beta-synthase activity.
- C275 (≠ I208) to Y: in CBSD; severe form; exhibits an activity lower than 4% of the wild-type enzyme; absent capacity to form multimeric quaternary structure; mutation to S: Reduced heme content and cystathionine beta-synthase activity.
- I278 (≠ W211) to S: in CBSD; loss of activity; to T: in CBSD; mild to severe form; common mutation; decreased expression; loss of cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; severely affects homotetramer formation by promoting formation of larger aggregates; dbSNP:rs5742905
- D281 (≠ E214) to N: in CBSD; loss of activity
- A288 (≠ L221) to T: in CBSD; protein expression is comparable to wild-type; significant decrease of enzyme activity; dbSNP:rs141502207
- E302 (vs. gap) to K: in CBSD; no effect on cystathionine beta-synthase activity; inhibited by AdoHcy and impaired activation by AdoMet; no effect on homotetramer formation; dbSNP:rs779270933
- G305 (= G235) to R: in CBSD; loss of cystathionine beta-synthase activity; no effect on homotetramer formation
- G307 (≠ S237) to S: in CBSD; moderate to severe form; linked with D-534; common mutation; loss of cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; no effect on homotetramer formation; dbSNP:rs121964962
- V320 (≠ C250) to A: in CBSD; has 36% of wild-type enzyme activity; dbSNP:rs781567152
- D321 (= D251) to V: in CBSD; loss of activity
- R336 (= R266) to C: in CBSD; protein expression is comparable to wild-type; loss of activity; absent capacity to form multimeric quaternary structure; dbSNP:rs398123151; to H: in CBSD; mild form; no effect on expression; exhibits an activity lower than 4% of the wild-type enzyme; altered stimulation by AdoMet; absent capacity to form multimeric quaternary structure; dbSNP:rs760417941
- L338 (= L268) to P: in CBSD; severe form; exhibits an activity lower than 4% of the wild-type enzyme; absent capacity to form multimeric quaternary structure
- G347 (= G277) to S: in CBSD; protein expression is comparable to wild-type; loss of activity; dbSNP:rs771298943
- S349 (≠ T279) binding pyridoxal 5'-phosphate; to N: in CBSD; severe form; exhibits an activity lower than 4% of the wild-type enzyme; absent capacity to form multimeric quaternary structure
- T353 (≠ N283) to M: in CBSD; protein expression is comparable to wild-type; significant decrease of enzyme activity; dbSNP:rs121964972
- R369 (≠ N299) to C: in CBSD; when linked with C-491 severe form; decreased cystathionine beta-synthase activity; decreased homotetramer formation; dbSNP:rs117687681
- D376 (= D306) to N: in CBSD; has significantly decreased levels of enzyme activity; dbSNP:rs1170128038
- R379 (≠ M309) to Q: in CBSD; exhibits an activity lower than 4% of the wild-type enzyme; absent capacity to form multimeric quaternary structure; dbSNP:rs763036586
- K384 (≠ T314) to E: in CBSD; severe form; dbSNP:rs121964967
Sites not aligning to the query:
- 18 R → C: results in 1/3 to 2/3 the enzyme activity of the wild-type; dbSNP:rs201827340
- 49 P → L: in CBSD; decreased expression; no effect on cystathionine beta-synthase activity; increased homotetramer formation; dbSNP:rs148865119
- 52 binding axial binding residue
- 58 R → W: in CBSD; linked with V-114; 18% of activity; dbSNP:rs555959266
- 65 binding axial binding residue; H → R: in CBSD; decreased cystathionine beta-synthase activity; inhibited by AdoMet and AdoHcy; decreased homotetramer formation; dbSNP:rs1191141364
- 69 A → P: in dbSNP:rs17849313
- 422 P → L: in CBSD; changed cystathionine beta-synthase activity; impaired stimulation by AdoMet; does not affect homotetramer formation; dbSNP:rs28934892
- 427 P → L: in CBSD; no effect on cystathionine beta-synthase activity; altered stimulation by AdoMet; dbSNP:rs863223434
- 435 I → T: in CBSD; no effect on cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; does not affect homotetramer formation
- 439 R → Q: in CBSD; no effect on cystathionine beta-synthase activity; increased homotetramer formation; dbSNP:rs756467921
- 444 D → N: in CBSD; decreased expression; no effect on cystathionine beta-synthase activity; altered stimulation by AdoMet; increased homotetramer formation; dbSNP:rs28934891
- 449 V → G: in CBSD; no effect on cystathionine beta-synthase activity; altered stimulation by AdoMet
- 456 L → P: in CBSD; severe; exhibits an activity lower than 4% of the wild-type enzyme; absent capacity to form multimeric quaternary structure
- 466 S → L: in CBSD; increased cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; decreased homotetramer formation; dbSNP:rs121964971
- 500 S → L: in CBSD; no effect on cystathionine beta-synthase activity; altered stimulation by AdoMet; dbSNP:rs755106884
- 526 Q → K: in CBSD; has significantly decreased levels of enzyme activity
- 539 L → S: in CBSD; loss of cystathionine beta-synthase activity; impaired stimulation by AdoMet and AdoHcy; loss of homotetramer formation; dbSNP:rs121964968
- 540 L → Q: in CBSD; no effect on cystathionine beta-synthase activity; altered stimulation by AdoMet
- 548 R → Q: presents 60% of the wild-type activity; highly reduced capacity to form multimeric quaternary structure; dbSNP:rs150828989
3x43A Crystal structure of o-ureido-l-serine synthase (see paper)
42% identity, 98% coverage: 7:317/318 of query aligns to 4:302/316 of 3x43A
- active site: K42 (= K46), S264 (≠ T279)
- binding pyridoxal-5'-phosphate: K42 (= K46), N72 (= N76), F175 (≠ V188), G176 (= G189), T177 (= T190), T178 (≠ S191), T180 (= T193), G220 (= G235), S264 (≠ T279), P290 (≠ C305), D291 (= D306)
D2Z027 O-ureido-L-serine synthase; Cysteine synthase homolog DscD; O-acetylserine sulfhydrylase; EC 2.6.99.3; EC 2.5.1.47 from Streptomyces lavendulae (see paper)
42% identity, 98% coverage: 7:317/318 of query aligns to 5:303/324 of D2Z027
- K43 (= K46) modified: N6-(pyridoxal phosphate)lysine; mutation to A: Loss of catalytic activity, no longer binds N6-(pyridoxal phosphate)lysine.
- V74 (≠ T77) mutation to T: KM for OAS is 61 mM, KM for H(2)S is unchanged.
- Y97 (≠ N100) mutation to F: KM for OAS is unchanged, KM for H(2)S is 0.073 mM.; mutation to M: KM for OAS is 330 mM, KM for H(2)S is 0.084.
- S121 (≠ G124) mutation to A: KM for OAS is 140 mM, KM for H(2)S is 0.095 mM.; mutation to M: KM for OAS is 44 mM, KM for H(2)S is 0.20 mM.
Query Sequence
>WP_013842638.1 NCBI__GCF_000215085.1:WP_013842638.1
MSPIKCSSVLEAIGHTPLIELGRVGRDLPARIWAKAEFMNPGGSMKDRIALKMIEDAEQA
GKLKPGDTVLEETSGNTGIGLAMVCAIKGYPFIAVMSEGNSPERRQILKALGAKVELVPQ
AEGGKPGQVTGDDLALVEKRAGELQQELGAFWVNQFHNPSNCAGHYETTAQEIWEQMEGR
IDYFVDVVGTSGTFTGIATALKEKDPKIQCWVVEPASAPVLAGKPVTNPKHVLQGSSYAK
IPALWKPEVCDGYITVTDGEAIRTSRRLASEEGLLVGYTAGGNVAAALRMAGWCDPGANI
VTILCDSGMKYLSTDLFK
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory